• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SPACEOAR VUE SYSTEM; ABSORBABLE PERIRECTAL SPACER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SPACEOAR VUE SYSTEM; ABSORBABLE PERIRECTAL SPACER Back to Search Results
Model Number SV-2101
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bradycardia (1751); Cardiac Arrest (1762); Nausea (1970); Dizziness (2194); Loss of consciousness (2418); Diminished Pulse Pressure (2606); Syncope/Fainting (4411)
Event Date 03/02/2023
Event Type  Death  
Manufacturer Narrative
Block b3: the complainant reported the approximate procedure and death date of the event was on march 02, 2023.Blocks d4 and h4: the complainant was unable to report the lot number; therefore, the manufacture date and expiration date are unknown.Block h6: impact code f02 captures the reportable event, death.
 
Event Description
It was reported to boston scientific corporation that a spaceoar vue device was used during a spaceoar vue implant procedure on an unknown date, approximated to be four weeks before boston scientific corporation became aware of the event.The patient was given antibiotics before and after the procedure (keflex / cephalexin 1 tablet in the morning and one ablet in the evening).The patient was also given a prescription of norco (hydrocodone/acetaminophen 5/325 mg), 0.5mg ativan (taken 1 hour prior to procedure) before procedure.The skin was sprayed with ethyl chloride spray, and the injection area was cleaned with chlorhexidine prep before injecting lidocaine.The procedure was performed under local anesthetic (2% lidocaine 8-9mltotal; 2ml were placed under the skin, the rest was placed at apex of prostate), followed by hydro-dissection with 2-3 ml of saline, and aspiration was performed and confirmed there was no blood (the needle was in the right place).The hydrogel was placed under ultrasound guidance with urojet lidocaine gel in the rectum.After the injection of the hydrogel the stepper probe was removed, the patients' legs were lowered, and the patient was instructed to stay laying down to avoid being lightheaded.After 10-15 seconds the patient said that he was lightheaded.Ten (10) seconds later the patient rolled to his side and attempt to vomit, dry heaved, then the patient laid back down and said he wasn't feeling ok.The patient dried heaved again and laid down.The patient was cyanotic, and lost consciousness.It was reported the patient was breathing but was not responsive, rapid response turned into code blue, the patient was intubated and was injected with epinephrine and sodium bicarbonate.Cardiopulmonary resuscitation was performed for 20 minutes and since there was no shockable rhythm the patient was never shocked.The patient was then pronounced dead.An autopsy was performed and reported the cause of death as natural causes due to hypertensive atherosclerotic cardiac disease.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPACEOAR VUE SYSTEM
Type of Device
ABSORBABLE PERIRECTAL SPACER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORK LIMITED
500 commander shea boulevard
quincy MA 02171
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key16765211
MDR Text Key313537059
Report Number3005099803-2023-02016
Device Sequence Number1
Product Code OVB
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K182971
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 04/18/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberSV-2101
Device Catalogue NumberSV-2101
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/22/2023
Initial Date FDA Received04/18/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age76 YR
Patient SexMale
Patient Weight70 KG
Patient RaceWhite
-
-